Cargando…
The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial
BACKGROUND: Although video-assisted thoracoscopic surgery (VATS) is increasingly used, the optimal analgesia strategy is still unknown. We explore the efficacy and safety of preemptive ultrasound-guided paravertebral block (PVB) combined with parecoxib during VATS. METHODS: Seventy-four patients wer...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025740/ https://www.ncbi.nlm.nih.gov/pubmed/32104057 http://dx.doi.org/10.2147/JPR.S244787 |
_version_ | 1783498564901535744 |
---|---|
author | Yang, Junling Hao, Zaijun Li, Wei Duan, Caiping Fan, Xiujuan Xin, Jing Ren, Chunguang |
author_facet | Yang, Junling Hao, Zaijun Li, Wei Duan, Caiping Fan, Xiujuan Xin, Jing Ren, Chunguang |
author_sort | Yang, Junling |
collection | PubMed |
description | BACKGROUND: Although video-assisted thoracoscopic surgery (VATS) is increasingly used, the optimal analgesia strategy is still unknown. We explore the efficacy and safety of preemptive ultrasound-guided paravertebral block (PVB) combined with parecoxib during VATS. METHODS: Seventy-four patients were divided into two groups. PVBs were performed before anesthesia induction under real-time ultrasound guidance. Visual analog scale (VAS) score with coughing at 48 h after surgery, postoperative sufentanil consumption and level of sedation (LOS) at 1, 4, 8, 12, 24, and 48 h postoperatively, intraoperative hemodynamics, satisfaction scores of patients and surgeons, remedial measures, time to chest tube removed and mobilization, adverse effects and hospital stay length were recorded. We also recorded inflammatory markers, respiratory function and the prevalence of chronic pain after surgery. RESULTS: VAS scores at rest and with coughing during the first 24 h after surgery were significantly lower in the P group (P<0.05). Consumption of sevoflurane, remifentanil, and dexmedetomidine was all significantly reduced in the P group (P<0.05). The consumption of sufentanil within 48 h after surgery, time to first dose and total dose of rescue ketorolac was significantly lower in the P group (P<0.05). The FEV1/FVC ratio was significantly higher in the P group at 1 and 3 d after surgery (P<0.05). Times to chest tube removal and mobilization were significantly shorter in the P group (P<0.05). Compared with the C group, the level of both ACTH and cortisol was significantly reduced in the P group at 1 and 3 d after surgery (P<0.05). CONCLUSION: PVB combined with parecoxib was associated with better pain relief, decreased sufentanil and ketorolac consumption, less hemodynamic instability, and a lower surgery-related stress response. However, the incidences of chronic pain 3 and 6 months after surgery and the risk of complication except urinary retention were not significantly different between groups. |
format | Online Article Text |
id | pubmed-7025740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-70257402020-02-26 The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial Yang, Junling Hao, Zaijun Li, Wei Duan, Caiping Fan, Xiujuan Xin, Jing Ren, Chunguang J Pain Res Original Research BACKGROUND: Although video-assisted thoracoscopic surgery (VATS) is increasingly used, the optimal analgesia strategy is still unknown. We explore the efficacy and safety of preemptive ultrasound-guided paravertebral block (PVB) combined with parecoxib during VATS. METHODS: Seventy-four patients were divided into two groups. PVBs were performed before anesthesia induction under real-time ultrasound guidance. Visual analog scale (VAS) score with coughing at 48 h after surgery, postoperative sufentanil consumption and level of sedation (LOS) at 1, 4, 8, 12, 24, and 48 h postoperatively, intraoperative hemodynamics, satisfaction scores of patients and surgeons, remedial measures, time to chest tube removed and mobilization, adverse effects and hospital stay length were recorded. We also recorded inflammatory markers, respiratory function and the prevalence of chronic pain after surgery. RESULTS: VAS scores at rest and with coughing during the first 24 h after surgery were significantly lower in the P group (P<0.05). Consumption of sevoflurane, remifentanil, and dexmedetomidine was all significantly reduced in the P group (P<0.05). The consumption of sufentanil within 48 h after surgery, time to first dose and total dose of rescue ketorolac was significantly lower in the P group (P<0.05). The FEV1/FVC ratio was significantly higher in the P group at 1 and 3 d after surgery (P<0.05). Times to chest tube removal and mobilization were significantly shorter in the P group (P<0.05). Compared with the C group, the level of both ACTH and cortisol was significantly reduced in the P group at 1 and 3 d after surgery (P<0.05). CONCLUSION: PVB combined with parecoxib was associated with better pain relief, decreased sufentanil and ketorolac consumption, less hemodynamic instability, and a lower surgery-related stress response. However, the incidences of chronic pain 3 and 6 months after surgery and the risk of complication except urinary retention were not significantly different between groups. Dove 2020-02-11 /pmc/articles/PMC7025740/ /pubmed/32104057 http://dx.doi.org/10.2147/JPR.S244787 Text en © 2020 Yang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Yang, Junling Hao, Zaijun Li, Wei Duan, Caiping Fan, Xiujuan Xin, Jing Ren, Chunguang The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial |
title | The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial |
title_full | The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial |
title_fullStr | The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial |
title_full_unstemmed | The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial |
title_short | The Efficacy and Safety of Paravertebral Block Combined with Parecoxib During Video-Assisted Thoracic Surgery: A Randomized Controlled Trial |
title_sort | efficacy and safety of paravertebral block combined with parecoxib during video-assisted thoracic surgery: a randomized controlled trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025740/ https://www.ncbi.nlm.nih.gov/pubmed/32104057 http://dx.doi.org/10.2147/JPR.S244787 |
work_keys_str_mv | AT yangjunling theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT haozaijun theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT liwei theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT duancaiping theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT fanxiujuan theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT xinjing theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT renchunguang theefficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT yangjunling efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT haozaijun efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT liwei efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT duancaiping efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT fanxiujuan efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT xinjing efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial AT renchunguang efficacyandsafetyofparavertebralblockcombinedwithparecoxibduringvideoassistedthoracicsurgeryarandomizedcontrolledtrial |